0001209191-17-064539.txt : 20171207
0001209191-17-064539.hdr.sgml : 20171207
20171207183555
ACCESSION NUMBER: 0001209191-17-064539
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171207
FILED AS OF DATE: 20171207
DATE AS OF CHANGE: 20171207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BYBEE CLINTON
CENTRAL INDEX KEY: 0001219043
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38311
FILM NUMBER: 171245782
MAIL ADDRESS:
STREET 1: 8755 W. HIGGINS ROAD
STREET 2: SUITE 1025
CITY: CHICAGO
STATE: IL
ZIP: 60631
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CRANDELL KEITH
CENTRAL INDEX KEY: 0001219039
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38311
FILM NUMBER: 171245783
MAIL ADDRESS:
STREET 1: 8755 W. HIGGINS ROAD
STREET 2: SUITE 1025
CITY: CHICAGO
STATE: IL
ZIP: 60631
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ARCH Venture Fund VIII, L.P.
CENTRAL INDEX KEY: 0001605598
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38311
FILM NUMBER: 171245786
BUSINESS ADDRESS:
STREET 1: 8755 W. HIGGINS ROAD, SUITE 1025
CITY: CHICAGO
STATE: IL
ZIP: 60631
BUSINESS PHONE: 776-380-6600
MAIL ADDRESS:
STREET 1: 8755 W. HIGGINS ROAD, SUITE 1025
CITY: CHICAGO
STATE: IL
ZIP: 60631
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ARCH Venture Partners VIII, LLC
CENTRAL INDEX KEY: 0001616165
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38311
FILM NUMBER: 171245785
BUSINESS ADDRESS:
STREET 1: 8755 W. HIGGINS ROAD, SUITE 1025
CITY: CHICAGO
STATE: IL
ZIP: 60631
BUSINESS PHONE: 7733806600
MAIL ADDRESS:
STREET 1: 8755 W. HIGGINS ROAD, SUITE 1025
CITY: CHICAGO
STATE: IL
ZIP: 60631
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ARCH Venture Partners VIII, L.P.
CENTRAL INDEX KEY: 0001616176
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38311
FILM NUMBER: 171245784
BUSINESS ADDRESS:
STREET 1: 8755 W. HIGGINS ROAD, SUITE 1025
CITY: CHICAGO
STATE: IL
ZIP: 60631
BUSINESS PHONE: 7733806600
MAIL ADDRESS:
STREET 1: 8755 W. HIGGINS ROAD, SUITE 1025
CITY: CHICAGO
STATE: IL
ZIP: 60631
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Denali Therapeutics Inc.
CENTRAL INDEX KEY: 0001714899
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 463872213
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 151 OYSTER POINT BLVD.
STREET 2: 2ND FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 866-8548
MAIL ADDRESS:
STREET 1: 151 OYSTER POINT BLVD.
STREET 2: 2ND FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2017-12-07
0
0001714899
Denali Therapeutics Inc.
DNLI
0001605598
ARCH Venture Fund VIII, L.P.
C/O ARCH VENTURE PARTNERS VIII, LLC
8755 W. HIGGINS ROAD, SUITE 1025
CHICAGO
IL
60631
0
0
1
0
0001616165
ARCH Venture Partners VIII, LLC
C/O ARCH VENTURE PARTNERS
8755 W. HIGGINS ROAD, SUITE 1025
CHICAGO
IL
60631
0
0
1
0
0001616176
ARCH Venture Partners VIII, L.P.
C/O ARCH VENTURE PARTNERS VIII, LLC
8755 W. HIGGINS ROAD, SUITE 1025
CHICAGO
IL
60631
0
0
1
0
0001219039
CRANDELL KEITH
C/O ARCH VENTURE PARTNERS VIII, LLC
8755 W. HIGGINS ROAD, SUITE 1025
CHICAGO
IL
60631
0
0
1
0
0001219043
BYBEE CLINTON
C/O ARCH VENTURE PARTNERS VIII, LLC
8755 W. HIGGINS ROAD, SUITE 1025
CHICAGO
IL
60631
0
0
1
0
Common Stock
312500
D
Series A-1 Preferred Stock
Common Stock
10068749
D
Series A-2 Preferred Stock
Common Stock
375000
D
Series B-1 Preferred Stock
Common Stock
312500
D
The shares are directly held by ARCH Venture Fund VIII, L.P. ("ARCH VIII"). ARCH Venture Partners VIII, L.P. (the "GPLP"), as the sole general partner of ARCH VIII, may be deemed to beneficially own certain of the shares held by ARCH VIII. ARCH Venture Partners VIII, LLC ("GPLLC"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH VIII. The GPLP and GPLLC disclaim beneficial ownership of such shares except to the extent of any pecuniary interest therein. Keith Crandell and Clinton Bybee, as managing directors of GPLLC, may be deemed to beneficially own the shares held by ARCH VIII. Messrs. Crandell and Bybee disclaim beneficial ownership of such shares except to the extent of any pecuniary interest therein.
The Series A-1 Preferred Stock shall automatically convert into shares of Common Stock on a 1:1 basis immediately prior to the completion of
the Issuer's initial public offering of Common Stock and has no expiration date.
The Series A-2 Preferred Stock shall automatically convert into shares of Common Stock on a 1:1 basis immediately prior to the completion of
the Issuer's initial public offering of Common Stock and has no expiration date.
The Series B-1 Preferred Stock shall automatically convert into shares of Common Stock on a 1:1 basis immediately prior to the completion of
the Issuer's initial public offering of Common Stock and has no expiration date.
ARCH Venture Partners VIII, LLC By: /s/ Mark McDonnell, Attorney-in-Fact
2017-12-07
ARCH Venture Fund VIII, L.P. By: ARCH Venture Partners VIII, L.P. By: /s/ Mark McDonnell, Attorney-in-Fact
2017-12-07
ARCH Venture Partners VIII, L.P. By: ARCH Venture Partners VIII, LLC By: /s/ Mark McDonnell, Attorney-in-Fact
2017-12-07
/s/ Mark McDonnell, as Attorney-in-Fact for Keith Crandell
2017-12-07
/s/ Mark McDonnell, as Attorney-in-Fact for Clinton Bybee
2017-12-07